31 Mar 2023
Assets111.55
Total Income113.12
EBITDA12.66
Profit After Tax5.82
NET Worth7.37
Reserves and Surplus-4.63
Total Borrowing66.39
At a glance
Updated 2026-09-11The shares listed at ₹92.00, a 1.10% move from the issue price. Anlon Healthcare is a Mainboard IPO with an issue size of ₹121.03 crore, proposed for listing on BSE, NSE. The offer opens on 26th Aug 2025 and closes on 29th Aug 2025. The issue structure includes a fresh issue of ₹121.03 crore. The current listing schedule points to 3rd Sep 2025.
Issue details
Listing atBSE, NSE
Issue typeBook Build Issue
Issue size₹121.03 Cr
Fresh issue₹121.03 Cr
Face value₹10
Price band₹86.00–₹91.00
Allotment1st Sep 2025
Listing3rd Sep 2025
Listing performance
Full performance ↗Issue price₹91.00
Listing price₹92.00
Current price—
Listing gain1.10%
Current return—
Price progressionIssue → Listing → Current
Grey market
GMP page ↗Latest GMP₹1.00
GMP / upper price1.10%
Est. listing₹92.00
GMP is unofficial sentiment data, not an exchange price.
Timeline
Opens26th Aug 2025
Closes29th Aug 2025
Allotment1st Sep 2025
Refund2nd Sep 2025
Demat2nd Sep 2025
Listing3rd Sep 2025
Subscription demand
Full bidding ↗Total7.12×
Lot size
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 164 | ₹14,924 |
Company
Incorporated2013
Use of proceeds
| Object | Amount |
|---|---|
| Funding capital expenditure requirements for Proposed Expansion | ₹30.72 Cr |
| Full or part repayment and/or prepayment of certain outstanding secured borrowingssecured borrowing (term loan)availed by the Company | ₹5.00 Cr |
| Funding the working capital requirements of the Company | ₹43.15 Cr |
| General Corporate Purposes | ₹27.03 Cr |
| Issue Expenses | ₹15.13 Cr |
| Total | ₹121.03 Cr |
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Revenue120.46₹ Cr · +80.6% vs prior year
EBITDA32.38₹ Cr · +108.0% vs prior year
PAT20.52₹ Cr · +112.4% vs prior year
Assets181.30₹ Cr · +41.6% vs prior year
Net Worth80.42₹ Cr · +282.4% vs prior year
Borrowing58.35₹ Cr · -21.7% vs prior year
3-year financial trendRevenue / EBITDA / PAT
₹ crore31 Mar 2024
Assets128.00
Total Income66.69
EBITDA15.57
Profit After Tax9.66
NET Worth21.03
Reserves and Surplus5.03
Total Borrowing74.56
31 Mar 2025
Assets181.30
Total Income120.46
EBITDA32.38
Profit After Tax20.52
NET Worth80.42
Reserves and Surplus40.57
Total Borrowing58.35
KPIs
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 40.45% |
| ROCE | 21.93% |
| Debt / Equity | 0.73% |
| RoNW | 25.51% |
| PAT Margin | 17.06% |
| EBITDA Margin | 26.88% |
| Price to Book Value | 4.51 |
Valuation & shareholding
Pre-IPO EPS5.15
Post-IPO EPS3.86
Pre-IPO P/E17.67
Post-IPO P/E23.57
Promoter holding pre70.26%
Promoter holding post52.68%
Market cap₹483.68 Cr.
Peer comparison
| Company | EPS | P/E | RoNW | NAV |
|---|---|---|---|---|
| Anlon Healthcare IPO | — | 23.57 x | — | — |
| Symbiotec Pharmalab IPO | — | 61.88 x | — | — |
| Sai Parenteral's IPO | — | 111.58 x | — | — |
| Corona Remedies IPO | — | 35.15 x | — | — |
Issue expenses
| Expense | Amount |
|---|---|
| Funding capital expenditure requirements for Proposed Expansion | ₹30.72 Cr |
| Full or part repayment and/or prepayment of certain outstanding secured borrowingssecured borrowing (term loan)availed by the Company | ₹5.00 Cr |
| Funding the working capital requirements of the Company | ₹43.15 Cr |
| General Corporate Purposes | ₹27.03 Cr |
| Issue Expenses | ₹15.13 Cr |
| Total | ₹121.03 Cr |
Registrar & lead managers
Registrar
Kfin Technologies Ltd.Lead managers
- Interactive Financial Services Ltd.
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-09-11.
IPO UPDATE ALERTS
Register for IPO Updates →Track Anlon Healthcare without missing an update
Register for subscription, GMP, allotment and listing notifications.